Immune cell infiltrate in ductal carcinoma in situ and the risk of dying from breast cancer: case-control study
CONCLUSION: The immune response to DCIS may influence the risk of dying from breast cancer.PMID:38395442 | PMC:PMC10890909 | DOI:10.1093/bjs/znae037
Source: The British Journal of Surgery - Category: Surgery Authors: Gunilla Rask Charlotta Wadsten Balazs Acs Johan Hartman Irma Fredriksson Hans Garmo Fredrik W ärnberg Malin Sund Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Carcinoma in Situ | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Study | Surgery | Sweden Health | UK Health | Women